Royal Bank Of Canada Dia Medica Therapeutics Inc. Transaction History
Royal Bank Of Canada
- $528 Billion
- Q2 2025
A detailed history of Royal Bank Of Canada transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 77,055 shares of DMAC stock, worth $402,227. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,055
Previous 155,031
50.3%
Holding current value
$402,227
Previous $587,000
48.89%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding DMAC
# of Institutions
57Shares Held
5.97MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.54MShares$8.01 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX650KShares$3.39 Million4.32% of portfolio
-
Geode Capital Management, LLC Boston, MA630KShares$3.29 Million0.0% of portfolio
-
First Manhattan CO New York, NY606KShares$3.17 Million0.01% of portfolio
-
Bleichroeder LP New York, NY382KShares$2 Million0.47% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $138M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...